A drug designed to slow down cognitive decline in Alzheimer’s, Kisunla, has so far been turned down for approval by the EU.This has led to huge frustration amongst Alzheimer’s experts that hailed the drug as a game-changer.Joining guest host Anna Daly to discuss is Dr. Laura O’Philbin, Research and Policy Manager at the Alzheimer Society of Ireland, Professor Sean Kennelly, Clinical Director of the Institute of Memory and Cognition in Tallaght University Hospital and listeners who have been personally impacted by the disease.Image: Eli Lilly

A drug designed to slow down cognitive decline in Alzheimer’s, Kisunla, has so far been turned down for approval by the EU. This has led to huge frustration amongst Alzheimer’s experts that hailed the drug as a game-changer. Joining guest host Anna Daly to discuss is Dr. Laura O’Philbin, Research and Policy Manager at the Alzheimer Society of Ireland, Professor Sean Kennelly, Clinical Director of the Institute of Memory and Cognition in Tallaght University Hospital and listeners who have been personally impacted by the disease. Image: Eli Lilly

Why has this Alzheimer’s drug not been approved?

Andrea Gilligan invites callers to have their&nbsp;say on the topics of the day - get in touch by emailing&nbsp;<a target="_blank" rel="noopener noreferrer" href="mailto:lunchtimelive@newstalk.com">lunchtimelive@newstalk.com</a> Listen and subscribe to Lunchtime Live&nbsp;on Apple Podcasts and Spotify. Download, listen and subscribe on the Newstalk App.CONVERSATION THAT COUNTS | Ireland’s national independent talk station for news, sport, analysis and entertainmentListen to Newstalk at&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="http://newstalk.com/listenlive">http://newstalk.com/listenlive</a>&nbsp;| Download the GoLoud app now, the new home for Newstalk

Society & Culture

Andrea Gilligan invites callers to have their say on the topics of the day - get in touch by emailing lunchtimelive@newstalk.com Listen and subscribe to Lunchtime Live on Apple Podcasts and Spotify. Download, listen and subscribe on the Newstalk App. CONVERSATION THAT COUNTS | Ireland’s national independent talk station for news, sport, analysis and entertainment Listen to Newstalk at http://newstalk.com/listenlive | Download the GoLoud app now, the new home for Newstalk

Andrea Gilligan invites callers to have their&nbsp;say on the topics of the day - get in touch by emailing&nbsp;<a href="mailto:lunchtimelive@newstalk.com" rel="noopener noreferrer">lunchtimelive@newstalk.com</a> Listen and subscribe to Lunchtime Live&nbsp;on Apple Podcasts and Spotify. Download, listen and subscribe on the Newstalk App.CONVERSATION THAT COUNTS | Ireland’s national independent talk station for news, sport, analysis and entertainmentListen to Newstalk at&nbsp;<a href="http://newstalk.com/listenlive" rel="noopener noreferrer">http://newstalk.com/listenlive</a>&nbsp;| Download the GoLoud app now, the new home for Newstalk

Share Why has this Alzheimer’s drug not been approved?

Sign up to save your podcasts

Why has this Alzheimer’s drug not been approved?

Why has this Alzheimer’s drug not been approved?

More shows like Lunchtime Live

Documentary on One Podcast

Documentary on Newstalk

Liveline

Newstalk Breakfast

Down To Business

Talking History with Patrick Geoghegan

The Last Word with Matt Cooper

Callan's Kicks

The Pat Kenny Show

Tech Talk with Jess Kelly

Real Health with Karl Henry

Around the World

Taking Stock

Breakfast Business with Joe Lynam

So You Think You're an Adult

Breakfast Briefing

The Home Show with Sinead Ryan

Travel on The Hard Shoulder

Brendan O'Connor

Today with David McCullagh

Crime World

The Mario Rosenstock Podcast

In The News

The Indo Daily

Inside the Crime

The Bookshelf with Ryan Tubridy

Path to Power

Let Me Explain with Seán Defoe

Life and Leadership Podcast

As I Remember It: Bertie Ahern & The Good Friday Agreement

Behind the Story

Breaking The Silence

Newstalk Daily